Senior FDA officials to step down over disagreement with White House on booster shots.
The duo was reportedly frustrated that the CDC and Advisory Committee on Immunization Practices (ACIP) was spearheading decisions that should be the responsibility of the FDA, the biotech news outlet Endpoint News reported, citing a former senior FDA leader as its source.
The source said that Gruber and Krause finally decided to step down after the Biden administration went ahead with a booster program starting the week of September 20 – without FDA approval.
The duo was reportedly frustrated that the CDC and Advisory Committee on Immunization Practices (ACIP) was spearheading decisions that should be the responsibility of the FDA, the biotech news outlet Endpoint News reported, citing a former senior FDA leader as its source.
The source said that Gruber and Krause finally decided to step down after the Biden administration went ahead with a booster program starting the week of September 20 – without FDA approval.
Senior FDA officials to step down over disagreement with White House on booster shots
Two Food and Drug Administration senior officials are reportedly stepping down from their posts over a disagreement with the White House on the administration of booster shots.
www.foxbusiness.com